Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis

AIM: We comprehensively analyzed how hepatitis C virus (HCV) eradication by interferon (IFN)-free direct-acting-antiviral-agents (DAAs) affects liver steatosis and atherogenic risk. METHODS: Patients treated with IFN-free-DAAs who underwent transient elastography before and at 24-weeks post-treatmen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Kawagishi, Naoki, Suda, Goki, Nakamura, Akinobu, Kimura, Megumi, Maehara, Osamu, Suzuki, Kazuharu, Nakamura, Akihisa, Ohara, Masatsugu, Izumi, Takaaki, Umemura, Machiko, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ogawa, Koji, Kudo, Yusuke, Nishida, Mutsumi, Miyoshi, Hideaki, Sakamoto, Naoya
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6303061/
https://ncbi.nlm.nih.gov/pubmed/30576386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0209615
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars